CD8+ DCs take up proteins from exogenous cell sources that are the source of the antigens, such as tumor cells and viral infected cells, process the proteins such that the derived peptides are cross-presented to CD8+ T cells after association with MHC receptors on the cell surface (1–11). This evidence concerns the gene CD8A and neoplasm.